Financial Personal
Verastem Oncology and STAAR Ovarian Cancer Foundation Establish the Inaugural Low-Grade Serous Ovarian Cancer (LGSOC) Awareness Day on September 9, 2024
LGSOC is a rare ovarian cancer often affecting younger women, with no FDA-approved treatments Approximately 80% of people treated for LGSOC will have their cancer come back BOSTON & HOUSTON, Texas — Verastem Oncology (Nasdaq: VSTM), a biop
BOSTON & HOUSTON, Texas -- Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, and the STAAR Ovarian Cancer Foundation today announced the first Low-Grade Serous Ovarian Cancer Awareness Day or “LGSOC Awareness Day” on September 9, 2024. Read More
